Latest filing published 15 Oct 2024 for AXIM BIOTECHNOLOGIES, INC..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -76.8%Entry US$0.10 · Close at T+365 US$0.02
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Catalina Valencia: trading record in brief
This profile gathers the share dealings of Catalina Valencia in Axim Biotechnologies, Inc. Over a trading history stretching from 24 August 2022 to 30 January 2024, the count stands at 2 filings.
Every open-market trade on record is a purchase: 2 purchases worth €100k, and no sale. The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2024: 1 purchase and no sales on the market.
The latest filing, published on 15 October 2024, reports an open-market purchase in Axim Biotechnologies, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Catalina Valencia
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,086,216 sharesCommon StockSEC:0001096906-24-002004:0Canonical exit: 29 Apr 2024 (T+90)
- 3,861,004 shares@ US$0.0259100.0% of flowCommon StockSEC:0001096906-22-002075:0Canonical exit: 22 Nov 2022 (T+90)
2 of 2 declarations